Neurotechnology refers broadly to technologies designed to measure, record, analyse, stimulate, modulate, model or otherwise interact with the nervous system. It encompasses a wide range of scientific and engineering approaches, from instruments used to measure neural activity to implanted stimulators, neural recording systems, computational models and interfaces that connect nervous-system signals with external devices. The term is therefore broader than Brain-Computer Interfaces, which represent one specific type of neurotechnological system.
Neurotechnology can involve the brain, spinal cord, peripheral nerves or combinations of these structures. Depending on its purpose, it can be used for research, diagnosis, monitoring, rehabilitation, treatment, assistive technology or experimental investigation. The field sits at the intersection of neuroscience, medicine, biomedical engineering, electronics, materials science, computing and signal processing.
The history of Neurotechnology follows the development of methods for observing and influencing the nervous system. Early neurological investigation relied heavily on behavioural observation and anatomical study, followed by techniques capable of recording electrical activity. The development of electroencephalography provided a means of measuring electrical activity from the scalp, while later neuroimaging methods enabled researchers to study brain structure and function using different physical signals. Implantable electrodes and electrical stimulation subsequently created more direct forms of interaction with neural tissue. Advances in computing transformed recorded neural signals into data that could be processed and analysed algorithmically. Modern Neurotechnology therefore includes both long-established clinical technologies and rapidly developing systems involving high-density recording, computational decoding, stimulation and closed-loop control.
Neurotechnology can be categorised according to whether it primarily records, stimulates, analyses or combines these functions. Recording systems detect neural or physiological activity, while stimulation systems deliver electrical, magnetic, optical or other forms of energy intended to influence neural activity. Analytical technologies transform recorded signals into measurements or predictions, and closed-loop systems combine sensing with stimulation so that the intervention can change according to detected neural activity. Devices may be non-invasive, minimally invasive or implanted.
The choice of approach depends on the required spatial and temporal resolution, target tissue, therapeutic objective, duration of use and acceptable level of medical intervention. These categories are not mutually exclusive because a single system can record neural activity, analyse it computationally and deliver stimulation based on the result.
Clinical Neurotechnology includes technologies used to diagnose neurological conditions, monitor neural activity or provide therapeutic stimulation. Electrical stimulation has been used in several medical contexts, including systems designed to influence abnormal neural activity or assist particular neurological functions. Neurotechnology is also relevant to rehabilitation, where neural or physiological signals can be combined with external devices to support training. Other systems can monitor brain activity during clinical procedures or research.
The clinical value of a neurotechnological system depends on whether it produces a meaningful improvement in diagnosis, treatment, function or quality of life, rather than simply demonstrating that neural signals can be detected. Clinical implementation consequently requires evidence, safety evaluation, appropriate patient selection and integration with conventional medical care.
Signal acquisition is one of the fundamental engineering challenges in Neurotechnology. Neural signals can be extremely small relative to sources of interference, and biological tissue can alter electrical, magnetic or optical measurements. Sensors therefore require appropriate physical placement, amplification, filtering and calibration. Implanted systems additionally require biocompatible materials, stable electrical interfaces, hermetic or otherwise appropriate packaging and mechanisms for long-term operation. Signal processing may involve filtering, feature extraction, statistical modelling and machine learning. The nervous system is dynamic, so signal characteristics can change with behaviour, attention, fatigue, disease progression, electrode movement or biological responses to an implant. Long-term neurotechnological systems consequently require methods for dealing with variability rather than assuming that neural signals remain constant.
Stimulation technologies introduce a different set of technical considerations because the system must deliver an intended physical stimulus without causing unacceptable effects. Electrical stimulation depends on parameters such as amplitude, pulse duration, frequency, electrode configuration and spatial distribution of current. The relationship between stimulation parameters and neural effects can be complex because neural tissue contains many interacting cell types and pathways.
Closed-loop approaches attempt to use measured signals to adjust stimulation dynamically, potentially making treatment more responsive to changing physiological conditions. Such systems require reliable sensing, rapid processing, validated control logic and fail-safe behaviour. The distinction between recording neural activity and deliberately modifying it is therefore fundamental when considering safety, clinical purpose and regulatory requirements.
Neurotechnology raises significant questions about ethics, privacy, autonomy, accessibility and long-term responsibility. Neural information may be sensitive even when the amount of information that can actually be decoded is limited. Users may need clear information about what a system records, what can be inferred from those recordings and how data are stored or shared. Implanted systems also raise questions about maintenance, device replacement, software updates and access to technical support over many years.
Security can become a safety issue when connected devices influence physiological functions or external equipment. Equity is another consideration because advanced neurotechnologies can be expensive and require specialised clinical infrastructure, potentially limiting access to particular populations. These issues become increasingly important as neurotechnological systems become more capable and more closely integrated with everyday computing.
Neurotechnology has an unusually broad relationship with other technologies in medicine. Brain-Computer Interfaces use neurotechnological sensing and decoding to create communication pathways with external systems, while Bionic Limbs and Prosthetic Technology can incorporate neural or muscular signals for control. Medical Artificial Intelligence can analyse neural recordings or assist with interpretation, while Health Information Technology provides infrastructure for storing and managing associated clinical information.
The term should nevertheless not be reduced to brain-computer communication because Neurotechnology also includes systems that have no external computer-control component, including technologies whose principal purpose is neural measurement or stimulation. Its defining feature is the technological interaction with the nervous system itself. Future development is likely to involve increasingly integrated sensing, computation, stimulation and adaptive control, while clinical usefulness will continue to depend on safety, evidence, reliability and appropriate human oversight.
